New pill shows promise for Long-Term ulcerative colitis control

NCT ID NCT05177835

Ongoing Disease control Sponsor: Abivax S.A. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 25 times

Summary

This study looks at the long-term safety and effectiveness of a daily pill called ABX464 for people with moderate to severe ulcerative colitis. About 200 participants who already improved in earlier studies will take the drug for up to 54 months. The goal is to see if the drug remains safe and helps keep the disease under control over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Antwerp University Hospital

Antwerp, Belgium
CHU Nantes - Hôtel Dieu

Nantes, France
CHU Saint Etienne - Hôpital Nord

Saint-Etienne, France
Centre Hospitalier Universitaire De Montpellier

Montpellier, France
Centre Hospitalier Universitaire Grenoble Alpes

Grenoble, France
Centro Medico Teknon

Barcelona, Spain
Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska

Wroclaw, Poland
Centrum Medyczne Oporow

Wroclaw, Poland
Centrum Medyczne Plejady

Krakow, Poland
Cliniq s.r.o.

Bratislava, Slovakia
Communal non-commercial enterprise "Cherkasy Regional Hospital of Cherkasy regional council"

Cherkasy, Ukraine
Communal non-commercial enterprise "Khmelnytska Regional Hospital" of Khmelnytskiy regional council

Khmelnytskyi, Ukraine
DRC Gyogyszervizsgalo Kozpont Kft.

Balatonfüred, Hungary
Endomed s.r.o

Vranov nad Topľou, Slovakia
Fakultni nemocnice u sv. Anny v Brne

Brno, Czechia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, Italy
GASTRO I, s.r.o.

Prešov, Slovakia
Goethe University Frankfurt

Frankfurt, Germany
Győr-Moson-Sopron Vármegyei Petz Aladár Egyetemi Oktató Kórház I. Belgyógyászat

Győr, Hungary
Humanitas Mirasole S.p.A.

Rozzano, Italy
IRCCS Ospedale Sacro Cuore Don Calabria

Verona, Italy
Institut des MICI

Neuilly-sur-Seine, France
Kliničko bolnički centar Zvezdara

Belgrade, Serbia
LexMedica

Wroclaw, Poland
Medical Network Sp. z o.o.

Warsaw, Poland
Medical University of Vienna

Vienna, Austria
Medicome Sp. z o. o.

Oświęcim, Poland
Medizinische Hochschule Hannover

Hanover, Germany
Medizinische Universitaet Innsbruck

Innsbruck, Austria
Nemocnice Slany

Slaný, Czechia
Niepubliczny Zaklad Opieki Zdrowotnej Neuromed M. i M. Nastaj sp. p

Lublin, Poland
Opšta bolnica "Đorđe Joanović" Zrenjanin Odsek za gastroenterologiju

Zrenjanin, Serbia
Ośrodek Badań Klinicznych "METABOLICA"

Tarnów, Poland
Samodzielny PZOZ w Lecznej

Łęczna, 21-010, Poland
Santa Sp. z o.o.

Warsaw, Poland
Semmelweis University

Budapest, Hungary
South Edmonton Gastroenterology

Edmonton, Canada
Splosna Bolnisnica Murska Sobota

Murska Sobota, Slovenia
Splošna bolnišnica Celje

Celje, Slovenia
Studiengesellschaft BSF UG (haftungsbeschraenkt)

Halle, Germany
Termedia Sp. z o.o (NSZOZ Termedica - Centrum Badan Klinicznych)

Poznan, Poland
Trialmed CRS

Piotrkow Trybunalski, Poland
UZ Leuven

Leuven, Belgium
Univerzitetni klinični center Maribor

Maribor, Slovenia
Vasutegeszseguegyi Nonprofit Koezhasznu Kft.

Debrecen, Hungary
Wojskowy Szpital Kliniczny w Lublinie

Lublin, Poland

Conditions

Explore the condition pages connected to this study.

ULCERATIVE COLITIS ULCERATIVE COLITIS